Paracrine Factors of Human Fetal MSCs Inhibit Liver Cancer Growth Through Reduced Activation of IGF-1R/PI3K/Akt Signaling

Niacinamide 0301 basic medicine Biomedical and clinical sciences Carcinoma, Hepatocellular Indoles 610 Receptor, IGF Type 1 Phosphatidylinositol 3-Kinases 03 medical and health sciences Fetus Genetic Drug Discovery Genetics Sunitinib Humans Pyrroles Molecular Biology Cell Proliferation Pharmacology Drug Discovery3003 Pharmaceutical Science Phenylurea Compounds Liver Neoplasms Mesenchymal Stem Cells Sorafenib 3. Good health Biological sciences Culture Media, Conditioned Gene Knockdown Techniques Molecular Medicine Proto-Oncogene Proteins c-akt Signal Transduction
DOI: 10.1038/mt.2015.13 Publication Date: 2015-01-26T12:14:42Z
ABSTRACT
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death in world. The multikinase inhibitor sorafenib only demonstrated marginal improvement overall survival for advanced disease prompted search alternative treatment options. Human mesenchymal stem cells (MSCs) have ability to home tumor cells. However, its functional roles on microenvironment remain controversial. Herein, we showed that conditioned media derived from human fetal MSC (CM-hfMSCs) expressed high level insulin growth factor binding proteins IGFBPs and can sequester free insulin-like factors (IGFs) inhibit HCC cell proliferation. inhibitory effect IGF signaling was further evident reduction activated IGF-1R PI3K/Akt, eventually induction cycle arrest. We also CM-hfMSCs could enhance therapeutic efficacy sunitinib. To best our knowledge, this first report show has a tumor-specific, antiproliferative not observed with normal hepatocyte patient-derived matched tissues. Our results thus suggest provide useful tool design alternative/adjuvant strategies HCC, especially related function potentiate effects chemotherapeutic drugs.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (68)